PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8548414-7	1996	The levels of TC, LDL-C, apoB, and E were also lowered by simvastatin at 80 or 400 mg/d, but to a lesser extent than at 200 mg/d, while the other parameters were not influenced at these doses.	Simvastatin	58-69	LDL	Sus scrofa	18-23	
17130282-2	2007	In clinical trials, ezetimibe plus simvastatin produces greater LDL-cholesterol reductions than does monotherapy.	Simvastatin	35-46	LDL	Sus scrofa	64-79	
8548414-8	1996	The simvastatin-induced decreases of LDL-C, HDL-C, and apoA-I, B, C-III, and E were significantly correlated among each other.	Simvastatin	4-15	LDL	Sus scrofa	37-42	
8548414-9	1996	These results show that the trend of responses in TC, LDL-C, apoB, apoC-III, and apoE to simvastatin in the FHC swine is similar to that observed in humans, although the drugs is less potent and efficacious in swine, while the results are different from those in humans with regard to the remaining parameters.	Simvastatin	89-100	LDL	Sus scrofa	54-59